Skip to main content
SpringerLink
Log in

Xanthines (Caffeine) and Nicotine

  • Chapter
Drug and Alcohol Abuse

  • 2380 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Undem, B. J., & Lichtenstein, L. M. Drugs used in the treatment of asthma. In J. G. Hardman, L. E. Limbird, & A. G. Gilman (Eds.), The Pharmacological Basis of Therapeutics (10th ed.). New York: McGraw-Hill, 2001, pp. 733–754.

    Google Scholar 

  2. Strain, E. C., & Griffiths, R. M. Caffeine-related disorders. In B. J. Sadock & V. A. Sadock (Eds.), Comprehensive Textbook of Psychiatry (8th ed.). Baltimore, MD: Lippincott, Williams & Wilkins, 2004, pp. 1201–1210.

    Google Scholar 

  3. Juliano, L. M., & Griffiths, R. M. Caffeine. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance Abuse: A Comprehensive Textbook (4th ed.). Baltimore, MD: Lippincott, Williams & Wilkins, 2004, pp. 403–420.

    Google Scholar 

  4. Sjaastad, O., & Bakketeig, L. S. Caffeine-withdrawal headache. The Vågå study of headache epidemiology. Cephalalgia 24:241–249, 2004.

    Article  PubMed  Google Scholar 

  5. Fisone, G., Borgkvist, A., & Usiello, A. Caffeine as a psychomotor stimulant: Mechanism of action. Cellular and Molecular Life Sciences 61:857–872, 2004.

    Article  PubMed  Google Scholar 

  6. Ascherio, A., & Chen, H. Caffeinated clues from epidemiology of Parkinson’s disease. Neurology 61:S51–S54, 2003.

    PubMed  Google Scholar 

  7. Holmgren, P., Nordén-Pettersson, & Ahlner, J. Caffeine fatalities — four case reports. Forensic Science International 139:71–73, 2004.

    Article  PubMed  Google Scholar 

  8. Richardson, T., Rozkovec, A., Thomas, P., Ryder, J., Meckes, C., & Kerr, D. Influence of caffeine on heart rate variability in patients with longstanding type 1 diabetes. Diabetes Care 27:1127–1131, 2004.

    PubMed  Google Scholar 

  9. El Yacoubi, M., Ledent, C., Parmentier, M., Costentin, J., & Vaugeois, J. M. Caffeine reduces hypnotic effects of alcohol through adenosine A2A receptor blockade. Neuropharmacology 45:977–985, 2003.

    Article  PubMed  Google Scholar 

  10. Rosengren, A., Dotevall, A., Wilhelmsen, L., Thelle, D., & Johansson, S. Coffee and incidence of diabetes in Swedish women: A prospective 18-year follow-up study. Journal of Internal Medicine 255:89–95, 2004.

    Article  PubMed  Google Scholar 

  11. Lorist, M. M., & Tops, M. Caffeine, fatigue, and cognition. Brain and Cognition 53:82–94, 2003.

    Article  PubMed  Google Scholar 

  12. Halldner, L., Aden, U., Dahlberg, V., Johansson, B., Ledent, C., & Fredholm, B. B. The adenosine A(1) receptor contributes to the stimulatory, but not the inhibitory effect of caffeine on locomotion: a study in mice lacking adenosine A(1) and/or A(2A) receptors. Neuropharmacology 46:1008–1017, 2004.

    Article  PubMed  Google Scholar 

  13. Alsene, K., Deckert, J., Sand, P., & de Wit, H. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 28:1694–1702, 2003.

    Article  PubMed  Google Scholar 

  14. Karcz-Kubicha, M., Antoniou, K., Terasmaa, A., Quarta, D., Solinas, M., Justinova, Z., Pezzola, A., Reggio, R., Müller, C. E., Fuxe, K., Goldberg, S. R., Popoli, P., & Ferré, S. Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsychopharmacology 28:1281–1291, 2003.

    Article  PubMed  Google Scholar 

  15. Kaasinen, V., Aalto, S., Nagren, K., & Rinne, J. O. Dopaminergic effects of caffeine in the human striatum and thalamus. Neuroreport 15:281–285, 2004.

    Article  PubMed  Google Scholar 

  16. Lane, J. D., Pieper, C. F., Phillips-Bute, B. G., Bryant, J. E., & Kuhn, C. M. Caffeine affects cardiovascular and neuroendocrine activation at work and home. Psychosomatic Medicine 64:595–603, 2002.

    Article  PubMed  Google Scholar 

  17. Shilo, L., Sabbah, H., Hadari, R., Kovatz, S., Weinberg, U., Dolev, S., Dagan, Y., & Shenkman, L. The effects of coffee consumption on sleep and melatonin secretion. Sleep Medicine 3:271–273, 2002.

    Article  PubMed  Google Scholar 

  18. Liguori, A., & Robinson, J. H. Caffeine antagonism of alcohol-induced driving impairment. Drug and Alcohol Dependence 63:123–129, 2001.

    Article  PubMed  Google Scholar 

  19. Hartley, T. R., Lovallo, W. R., & Whitsett, T. L. Cardiovascular effects of caffeine in men and women. The American Journal of Cardiology 93:1022–1026, 2004.

    Article  PubMed  Google Scholar 

  20. Savoca, M. R., Evans, C. D., Wilson, M. E., Harshfield, G. A., & Ludwig, D. A. The association of caffeinated beverages with blood pressure in adolescents. Archives of Pediatric and Adolescent Medicine 158:473–477, 2004.

    Article  Google Scholar 

  21. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders (4th ed., text revision). Washington, DC: American Psychiatric Press, 2000.

    Google Scholar 

  22. Dager, S. R., Layton, M. E., Strauss, W., Richards, T. L., Heide, A., Friedman, S. D., Artru, A. A., Hayes, C. E., & Posse, S. Human brain metabolic response to caffeine and the effects of tolerance. American Journal of Psychiatry 156:229–237, 1999.

    PubMed  Google Scholar 

  23. Evans, S. M., & Griffiths, R. R. Caffeine withdrawal: a parametric analysis of caffeine dosing conditions. Journal of Pharmacology and Experimental Therapeutics 289:285–294, 1999.

    PubMed  Google Scholar 

  24. Hughes, J. R., & Oliveto, A. H. A systematic survey of caffeine intake in Vermont. Experimental and Clinical Psychopharmacology 5:393–398, 1997.

    Article  PubMed  Google Scholar 

  25. Hughes, J. R. McHugh, P., & Holtzman, S. Caffeine and schizophrenia. Psychiatric Services 49:1415–1417, 1998.

    PubMed  Google Scholar 

  26. Kendler, K. S., & Prescott, C. A. Caffeine intake, tolerance, and withdrawal in women: A population-based twin study. American Journal of Psychiatry 156:223–228, 1999.

    PubMed  Google Scholar 

  27. Holstege, C. P., Hunter, Y., Baer, A. B., Savory, J., Bruns, D. E., & Boyd, J. C. Massive caffeine overdose requiring vasopressin infusion and hemodialysis. Journal Toxicol Clinical Toxicology 41:1003–1007, 2003.

    Article  Google Scholar 

  28. Carrillo, J. A., Herraiz, A. G., Ramos, S. I., & Benítez, J. Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients. Journal of Clinical Psychopharmacology 18:311–316, 1998.

    Article  PubMed  Google Scholar 

  29. Bruce, M., Scott, N., Shine, P., & Lader, M. Anxiogenic effects of caffeine in patients with anxiety disorders. Archives of General Psychiatry 49:867–869, 1992.

    PubMed  Google Scholar 

  30. Breier, A., Charney, D. S., & Heinger, G. R. Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness. Archives of General Psychiatry 43:1029–1036, 1986.

    PubMed  Google Scholar 

  31. Ogawa, N., & Ueki, H. Secondary mania caused by caffeine (Letters to the Editor). General Hospital Psychiatry 25:136–144, 2003.

    Article  Google Scholar 

  32. DiMonda, V., Nicolodi, M., Aloisio, A., Del Bianco, P., Fonzari, M., Grazioli, I., Uslenghi, C., Vecchiet, L., & Sicuteri, F. Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: A multicenter, randomized, crossover trial. Headache 43:835–844, 2003.

    Article  Google Scholar 

  33. Ascherio, A., Zhang, S. J., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. Prospective study of caffeine consumption and risk of Parkinson’s Disease in men and women. Annals of Neurology 50:56–63, 2001.

    Article  PubMed  Google Scholar 

  34. Agardh, E. E., Carlsson, S., Ahlbom, A., Efendic, S., Grill, V., Hammar, N., Hilding, A., & Östenson, C.-G. Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women. Journal of Internal Medicine 255:645–652, 2004.

    Article  PubMed  Google Scholar 

  35. Van Dam, R. J., & Feskens, E. J.M. Coffee consumption and risk of type 2 diabetes mellitus. The Lancet 360:1477–1478, 2002.

    Article  Google Scholar 

  36. Leitzmann, M. F., Stampfer, M. J., Willett, W. C., Spiegelman, D., Colditz, G. A., & Giovannucci, E. L. Coffee intake is associated with lower risk of symptomatic gallstone disease in women. Gastroenterology 123:1823–1830, 2002.

    Article  PubMed  Google Scholar 

  37. Pehl, C., Pfeiffer, A., Wendl, B., & Kaess, H. The effect of decaffeination of coffee on gastro-oesophageal reflux in patients with reflux disease. Alimentary Pharmacology and Therapeutics 11:483–486, 1997.

    Article  PubMed  Google Scholar 

  38. Kelly, T. L., Mitler, M. M., & Bonnet, M. H. Sleep latency measures of caffeine effects during sleep deprivation. Electroencephalography and Clinical Neurophysiology 102:397–400, 1997.

    Article  PubMed  Google Scholar 

  39. Slattery, M. L., Caan, B. J., Anderson, K. E., & Potter, J. D. Intake of fluids and methylx-anthine-containing beverages: Association with colon cancer. International Journal of Cancer 81:199–204, 1999.

    Article  Google Scholar 

  40. Signorello, L. B., & McLaughlin, J. K. Maternal caffeine consumption and spontaneous abortion: A review of the epidemiologic evidence. Epidemiology 15:229–239, 2004.

    Article  PubMed  Google Scholar 

  41. Taylor, P. Agents acting at the neuromuscular junction and autonomic ganglia. In J. G. Hardman, L. E. Limbird, & A. G. Gilman (Eds.), The Pharmacological Basis of Therapeutics (10th ed.). New York: McGraw-Hill, 2001, pp. 193–214.

    Google Scholar 

  42. Strong, D. R., Kahler, C.W., Ramsey, S. E., & Brown, R. A. Finding order in the DSM-IV nicotine dependence syndrome: A rasch analysis. Drug and Alcohol Dependence 72:151–162, 2003.

    Article  PubMed  Google Scholar 

  43. Hughes, J. R. Distinguishing nicotine dependence from smoking. Archives of General Psychiatry 58:817–818, 2001.

    Article  PubMed  Google Scholar 

  44. Li, M. D., Cheng, R., Ma, J. Z., & Swan, G. E. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 93:23–31, 2003.

    Article  Google Scholar 

  45. Hopfer, C. J., Stallings, M. C., & Hewitt, J. K. Common genetic and environmental vulnerability for alcohol and tobacco use in a volunteer sample of older female twins. Journal of Studies on Alcohol 62:717–723, 2001.

    PubMed  Google Scholar 

  46. Bowers, B. J., McClure-Begley, T. D., Keller, J. J., Paylor, R., Collins, A. C., & Wehner, J. M. Deletion of the ∝7 nicotinic receptor subunit gene results in increased sensitivity to several behavioral effects produced by alcohol. Alcoholism: Clinical and Experimental Research 29:295–302, 2005.

    Article  Google Scholar 

  47. Schmitz, J. M., & DeLaune, K. A. Nicotine. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance Abuse: A Comprehensive Textbook (4th ed.). Baltimore, MD: Lippincott, Williams & Wilkins, 2004, pp. 387–402.

    Google Scholar 

  48. Perez-Stable, E., Herrera, B., Jacob, P., III, & Benowitz, N. L. Nicotine metabolism and intake in black and white smokers. Journal of the American Medical Association 280:152–156, 1998.

    Article  PubMed  Google Scholar 

  49. Rassoulpour, A., Wu, H.-Q., Albuquerque, E. X., & Schwarcz, R. Prolonged nicotine administration results in biphasic, brain-specific changes in kynurenate levels in the rat. Neuropsychopharmacology 30:697–704, 2005.

    Article  PubMed  Google Scholar 

  50. Rose, J. E., Behm, F. M., Westman, E. C., Mathew, R. J., London, E. D., Hawk, T. C., Turkington, T. G., & Coleman, R. E. PET studies of the influences of nicotine on neural systems in cigarette smokers. American Journal of Psychiatry 160:323–333, 2003.

    Article  PubMed  Google Scholar 

  51. Tapper, A. R., McKinney, S. L., Nashmi, R., Schwarz, J., Deshpande, P., Labarca, C., Whiteaker, P., Marks, M. J., Collins, A. C., & Lester, H. A. Nicotine activation of (4 receptors: Sufficient for reward, tolerance and sensitization. Science 306:1029–1032, 2004.

    Article  PubMed  Google Scholar 

  52. Blomqvist, O., Hernandez-Avila, C. A., Van Kirk, J., Rose, J. E., & Kranzler, H. R. Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol. Alcoholism: Clinical and Experimental Research 26:326–331, 2002.

    Article  Google Scholar 

  53. Picciotto, M. R., & Corrigall, W. A. Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. The Journal of Neuroscience 22:3338–3341, 2002.

    PubMed  Google Scholar 

  54. Brody, A. L., Olmstead, R. E., London, E. D., Farahi, J., Meyer, J. H., Grossman, P., Lee, G. S., Huang, J., Hahn, E. L., & Mandelkern, M. A. Smoking-induced ventral striatum dopamine release. American Journal of Psychiatry 161:1211–1218, 2004.

    Article  PubMed  Google Scholar 

  55. Klimek, V., Zhu, Y., Dilley, G., Konick, L., Overholser, J. C., Meltzer, H. Y., May, W. L., Stockmeier, C. A., & Ordway, G. A. Effects of long-term cigarette smoking on the human locus coeruleus. Archives of General Psychiatry 58:821–827, 2001.

    Article  PubMed  Google Scholar 

  56. Chen, H., Vlahos, R., Bozinovski, S., Jones, J., Anderson, G. P., & Morris, M. J. Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice. Neuropsychopharmacology 30:713–719, 2005.

    PubMed  Google Scholar 

  57. Berggren, U., Fahlke, C., Eriksson, M., & Balldin, J. Tobacco use is associated with reduced central serotonergic neurotransmission in Type 1 alcohol-dependent individuals. Alcoholism: Clinical and Experimental Research 27:1257–1261, 2003.

    Article  Google Scholar 

  58. Benowitz, N. L., Peez-Stable, E. J., Herrera, B., & Jacob, P., III. Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. Journal of the National Cancer Institute 94:108–115, 2002.

    PubMed  Google Scholar 

  59. Ebbert, J. O., Rowland, L. C., Montori, V. M., Vickers, K. S., Erwin, P. J., & Dale, L. C. Treatments for spit tobacco use: a quantitative systematic review. Addiction 98:569–583, 2003.

    Article  PubMed  Google Scholar 

  60. Sacco, K. A., Termine, A., Seyal, A., Dudas, M. M., Vessicchio, J. C., Krishnan-Sarin, S., Jatlow, P. I., Wexler, B. E., & George, T. P. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: Involvement of nicotinic receptor mechanisms. Archives of General Psychiatry 62:649–659, 2005.

    Article  PubMed  Google Scholar 

  61. Cheeta, S., Irvine, E. E., Tucci, S., Sandhu, J., & File, S. E. In adolescence, female rats are more sensitive to the anxiolytic effect of nicotine than are male rats. Neuropsychopharmacology 25:601–607, 2001.

    Article  PubMed  Google Scholar 

  62. Phillips, A.N., Wannamethee, S.G., Walker, M., Thomson, A., & Smith, G.D. Life expectancy in men who have never smoked and those who have smoked continuously: 15-year follow-up of large cohort of middle aged British men. British Medical Journal 313:907–908, 1996.

    PubMed  Google Scholar 

  63. Substance Abuse and Mental Health Services Administration. Results From the 2002 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NHSDA Series H-22, DHHS Publication No. SMA 03-3836). Rockville, MD, 2003.

    Google Scholar 

  64. Breslau, N., Johnson, E.O., Hiripi, E., & Kessler, R. Nicotine dependence in the United States. Archives of General Psychiatry 58:810–816, 2001.

    Article  PubMed  Google Scholar 

  65. Anthony, J. C., & Echeagaray-Wagner, F. Epidemiologic analysis of alcohol and tobacco use: Patterns of co-occurring consumption and dependence in the United States. Alcohol Research & Health 24:201–208, 2000.

    Google Scholar 

  66. Anthony, J. C. Epidemiology of drug dependence. In K. L. Davis, D. Charney, J. T. Coyle, & C. Nemeroff (Eds.), Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia, PA: Lippincott Williams & Wilkins, 2002.

    Google Scholar 

  67. Johnston, L. D., O’Malley, P. M., & Bachman, J. R. Monitoring the Future National Survey Results on Drug Use, 1975–2002, Volume I: Secondary school Students (NIH Publication No. 03-5375). Bethesda, MD: National Institute on Drug Abuse, 2003.

    Google Scholar 

  68. Collins, A. C. Genetic influences on tobacco use: A review of human and animal studies. International Journal of Addictions 25:35–55, 1991.

    Google Scholar 

  69. Bricker, J. B., Leroux, B. G., Peterson, A. V., Jr., Kealey, K. A., Sarason, I. G., Andersen, M. R., & Marek, P. M. Nine-year prospective relationship between parental smoking cessation and children’s daily smoking. Addiction 98:585–593, 2003.

    Article  PubMed  Google Scholar 

  70. Audrain-McGovern, J., Lerman, C., Wileyto, E. P., Rodriguez, D., & Shields, P. G. Interacting effects of genetic predisposition and depression on adolescent smoking progression. American Journal of Psychiatry 161:1224–1230, 2004.

    Article  PubMed  Google Scholar 

  71. Schmitz, N., Kruse, J., & Kugler, J. Disabilities, quality of life, and mental disorders associated with smoking and nicotine dependence. American Journal of Psychiatry 160:1670–1676, 2003.

    Article  PubMed  Google Scholar 

  72. Hughes, J. R., Fiester, S., Goldstein, M., et al. Practice guidelines for the treatment of patients with nicotine. American Journal of Psychiatry 153(suppl):1–29, 1996.

    Google Scholar 

  73. Abroms, L., Simons-Morton, B., Haynie, D. L., & Chen, R. Psychosocial predictors of smoking trajectories during middle and high school. Addiction 100:852–861, 2005.

    Article  PubMed  Google Scholar 

  74. Russell, M. A. H. The nicotine addiction trap: A 40-year sentence for four cigarettes. British Journal of Addiction 85:293–300, 1990.

    Article  PubMed  Google Scholar 

  75. West, R., McEwen, A., Bolling, K., & Owen, L. Smoking cessation and smoking patterns in the general population: A 1-year follow-up. Addiction 96:891–902, 2001.

    Article  PubMed  Google Scholar 

  76. Meyer, C., Rumpf, H.-J., Schumann, A., Hapke, U., John, U. Intentionally reduced smoking among untreated general population smokers: prevalence, stability, prediction of smoking behaviour change and differences between subjects choosing either reduction or abstinence. Addiction 98:1101–1110, 2003.

    Article  PubMed  Google Scholar 

  77. Cooney, J. L., Cooney, N. L., Pilkey, D. T., Kranzler, H. R., & Oncken, C. A. Effects of nicotine deprivation on urges to drink and smoke in alcoholic smokers. Addiction 98:913–921, 2003.

    Article  PubMed  Google Scholar 

  78. Jackson, K. M., Sher, K. J., Cooper, M. L., & Wood, P. K. Adolescent alcohol and tobacco use: Onset, persistence and trajectories of use across two samples. Addiction 97:517–531, 2002.

    Article  PubMed  Google Scholar 

  79. Bierut, L. J., Rice, J. P., Goate, A., Hinrichs, A. L., Saccone, N. L., Foroud, T., Edenberg, H. J., Cloninger, R., Begleiter, H., Conneally, P. M., Crowe, R. R., Hesselbrock, V., Li, T.-K., Nurnberger, J. I., Jr., Porjesz, B., Schuckit, M. A., & Reich, T. A genomic scan for habitual smoking in families of alcoholics: Common and specific genetic factors in substance dependence. American Journal of Medical Genetics, 124:19–27, 2005.

    Google Scholar 

  80. Richter, K. P., Ahluwalia, H. K., Mosier, M. C., Nazir, N., & Ahluwalia, J. S. A population-based study of cigarette smoking among illicit drug users in the United States. Addiction 97:861–869, 2002.

    Article  PubMed  Google Scholar 

  81. Ferguson, J., Bauld, L., Chesterman, J., & Judge, K. The English smoking treatment services: One-year outcomes. Addiction 100:59–69, 2005.

    Article  PubMed  Google Scholar 

  82. Jacobsen, L. K., Krystal, J. H., Mencl, W. E., Westervald, M., Frost, S. J., & Pugh, K. R. Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biological Psychiatry 57:56–66, 2005.

    Article  PubMed  Google Scholar 

  83. Dierker, L. C., Avenevoli, S., Stolar, M., & Merikangas, K. R. Smoking and depression: An examination of mechanisms of comorbidity. American Journal of Psychiatry 159:947–953, 2002.

    Article  PubMed  Google Scholar 

  84. Zubieta, J.-K., Heitzig, M. M., Xu, Y., Koeppe, R. A., Ni, L., Guthrie, S., & Domino, E. F. Regional cerebral blood flow responses to smoking in tobacco smokers after overnight abstinence. American Journal of Psychiatry 162:567–577, 2005.

    Article  PubMed  Google Scholar 

  85. Schneider, N. G., Olmstead, R., Vaghaiwalla Mody, F., Doan, K., Franzon, M., Jarvik, M. E., & Steinberg, C. Efficacy of a nicotine nasal spray in smoking cessation: A placebo-controlled, double-blind trial. Addiction 90:1671–1682, 1995.

    Article  PubMed  Google Scholar 

  86. George, T. P., Vessicchio, J. C., Termine, A., Bregartner, T. A., Feingold, A., Rounsaville, B. J., & Kosten, T. R. A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry 52:53–61, 2002.

    Article  PubMed  Google Scholar 

  87. Hall, S. M., Humfleet, G. L., Reus, V. I., Munoz, R. F. & Cullen, J. Extended nortriptyline and psychological treatment for cigarette smoking. American Journal of Psychiatry 161:2100–2107, 2004.

    Article  PubMed  Google Scholar 

  88. Goldstein, M. G. Bupropion sustained release and smoking cessation. Journal of Clinical Psychiatry 4:66–72, 1998.

    Google Scholar 

  89. Ashenden, R., Silagy, C. A., Lodge, M., & Fowler, G. A meta-analysis of the effectiveness of acupuncture in smoking cessation. Drug and Alcohol Review 16:33–40, 1997.

    Article  PubMed  Google Scholar 

  90. Breslau, N., Schultz, L. R., Johnson, E. O., Peterson, E. L., & Davis, G. C. Smoking and the risk of suicidal behavior: A prospective study of a community sample. Archives of General Psychiatry 62:328–334, 2005.

    Article  PubMed  Google Scholar 

  91. Grant, B. F., Hasin, D. S., Chou, P., Stinson, F. S., & Dawson, D. A. Nicotine dependence and psychiatric disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 61:1107–1115, 2004.

    Article  PubMed  Google Scholar 

  92. Tregellas, J. R., Tanabe, J. L., Martin, L. F., & Freedman, R. fMRI response to nicotine during a smooth pursuit eye movement task in schizophrenia. American Journal of Psychiatry 162:391–393, 2005.

    Article  PubMed  Google Scholar 

  93. Smith, R. C., Singh, A., Infante, M., Khandat, A., & Kloos, A. Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology 27:479–497, 2002.

    Article  PubMed  Google Scholar 

  94. Weiser, M., Reichenberg, A., Grotto, I., Yasvitzsky, R., Rabinowitz, J., Lubin, G., Nahon, D., Knobler, H. Y., & Davidson, M. Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: A historical-prospective cohort study. American Journal of Psychiatry 161:1219–1223, 2004.

    Article  PubMed  Google Scholar 

  95. Zammit, S., Allebeck, P., Dalman, C., Lundberg, I., Hemmingsson, T., & Lewis, G. Investigating the association between cigarette smoking and schizophrenia in a cohort study. American Journal of Psychiatry 160:2216–2220, 2003.

    Article  PubMed  Google Scholar 

  96. Goodwin, R., & Hamilton, S. P. Cigarette smoking and panic: The role of neuroticism. American Journal of Psychiatry 159:1208–1213, 2002.

    Article  PubMed  Google Scholar 

  97. Isensee, B., Wittchen, H.-U., Stein, M. R., Hofler, M., & Lieb, R. Smoking increases the risk of panic: Findings from a prospective community study. Archives of General Psychiatry 60:692–700, 2003.

    Article  PubMed  Google Scholar 

  98. Johnson, J. G., Cohen, P., Pine, D. S., Klein, D. F., Kasen, S., & Brook, J. S. Association between cigarette smoking and anxiety disorders during adolescence and early adulthood. Journal of the American Medical Association 284:2348–2351, 2000.

    Article  PubMed  Google Scholar 

  99. McGee, R., Williams, S., & Nada-Raja, S. Is cigarette smoking associated with suicidal ideation among young people? American Journal of Psychiatry 162:619–620, 2005.

    Article  PubMed  Google Scholar 

  100. Malone, K. M., Waternaux, C., Haas, G. L., Cooper, T. B., Li, S., & Mann, J. J. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. American Journal of Psychiatry 160:773–779, 2003.

    Article  PubMed  Google Scholar 

  101. Breslau, N., Novak, S. P., & Kessler, R. C. Psychiatric disorders and stages of smoking. Biological Psychiatry 55:69–76, 2004.

    Article  PubMed  Google Scholar 

  102. Kendler, K. S., Neale, M. C., MacLean, C. J., Heath, A. C., Eaves, L. J. & Kessler, R.C. Smoking and major depression: A causal analysis. Archives of General Psychiatry 50:36–43, 1993.

    PubMed  Google Scholar 

  103. Doll, R., Peto, R., Boreham, J., & Sutherland, I. Mortality in relation to smoking: 50 years’ observation on male British doctors. British Medical Journal 328:1519–1528, 2004.

    PubMed  Google Scholar 

  104. Zamani, M. R., & Allen, Y. S. Nicotine and its interaction with β-amyloid protein: a short review. Biological Psychiatry 49:221–232, 2001.

    Article  PubMed  Google Scholar 

  105. Newhouse, P. A., Potter, A., Kelton, M., & Corwin, J. Nicotinic treatment of Alzheimer’s disease. Biological Psychiatry 49:268–278, 2001.

    Article  PubMed  Google Scholar 

  106. Howard, G., Wagenknecht, L. E., Burke, G. L., Diez-Roux, A., Evans, G.W., McGovern, P., Nieto, F. J., & Tell, G. S. Cigarette smoking and progression of atherosclerosis: The atherosclerosis risk in communities (ARIC) study. Journal of the American Medical Association 279:119–124, 1998.

    Article  PubMed  Google Scholar 

  107. Rosenberg, L., Palmer, J. R., & Shapiro, S. Decline in the risk of myocardial infarction among women who stop smoking. New England Journal of Medicine 322:213–217, 1990.

    Article  PubMed  Google Scholar 

  108. Parath, A. J. & Fried, P. A. Effects of prenatal cigarette and marijuana exposure on drug use among offspring. Neurotoxicology and Teratology 27:267–277, 2005.

    Article  Google Scholar 

  109. Abreu-Villaca, Y., Seidler, F. J., & Slotkin, T. A. Does prenatal nicotine exposure sensitize the brain to nicotine-induced neurotoxicity in adolescence? Neuropsychopharmacology 29:1440–1450, 2004.

    Article  PubMed  Google Scholar 

  110. Brennan, P. A., Grekin, E. R., Mortensen, E. L., & Mednick, S. A. Relationship of maternal smoking during pregnancy with criminal arrest and hospitalization for substance abuse in male and female adult offspring. American Journal of Psychiatry 159:48–54, 2002.

    Article  PubMed  Google Scholar 

  111. Linnet, K. M., Dalsgaard, S., Obel, C., Wisborg, K. Henriksen, T. B., Rodriguez, A L., Kotimaa, A., Moilanen, I., Thomsen, P. H., Olsen, J., & Jarvelin, R. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: Review of the current evidence. American Journal of Psychiatry 160:1028–1040, 2003.

    Article  PubMed  Google Scholar 

  112. Thapar, A., Fowler, T., Rice, F., Scourfield, J., van den Bree, M., Thomas, H., Harold, G., & Hay, D. Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. American Journal of Psychiatry 160:1985–1989, 2003.

    Article  PubMed  Google Scholar 

  113. Gold, D. R., Wang, X., Wypij, D., Speizer, F. E., Ware, J. H., & Dockery, D. W. Effects of cigarette smoking on lung function in adolescent boys and girls. New England Journal of Medicine 335:931–937, 1996.

    Article  PubMed  Google Scholar 

  114. Jensen, J., Christiansen, C., & Rodbro, P. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. New England Journal of Medicine 313:973–975, 1985.

    Article  PubMed  Google Scholar 

  115. Steenland, K. Passive smoking and the risk of heart disease. Journal of the American Medical Association 267:94–99, 1992.

    Article  PubMed  Google Scholar 

  116. Cruickshanks, K. J., Klein, R., Klein, B. E. K., Wiley, T. L., Nondahl, D. M., & Tweed, T. S. Cigarette smoking and hearing loss. Journal of the American Medical Association 279:1715–1719, 1998.

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

(2006). Xanthines (Caffeine) and Nicotine. In: Drug and Alcohol Abuse. Springer, Boston, MA. https://doi.org/10.1007/0-387-25733-0_11

Download citation

Publish with us

Policies and ethics

Search

Navigation